Cost of Obamacare expected to soar as subsidies expire and insurers hike premiums
Insurers that offer plans through the ACA are planning an average premium increase of 15% for 2026 — the largest increase in seven years, according to an analysis published Friday from KFF, a health policy research group. The analysis is based on filings from more than 100 insurers in 19 states and Washington, D.C.
The increase will likely come on top of the loss of enhanced subsidies that helped people pay for ACA health plans by capping the costs at a certain proportion of their income.
The finalized plans — including how much more people will be expected to pay each month — are usually published around August.
The enhanced subsidies came out of the 2021 American Rescue Plan and broadened the number of people eligible, including many in the middle class. The Inflation Reduction Act, passed in 2022, extended the subsidies through 2025.
The domestic policy bill that President Donald Trump signed into law earlier this month, however, did not extend them further. (Subsidies for people with very low incomes that were put in place when the ACA was enacted will still be available.) The bill also added more hurdles for people who get their health insurance through the ACA, such as adding new paperwork requirements to renew coverage each year.
Nearly 4 million people were projected to lose their coverage next year if the subsidies weren't extended, according to a 2024 analysis from the Congressional Budget Office, a nonpartisan agency that provides budget and economic information to Congress.
A loss of coverage would also have implications for the cost of insurance.
With fewer people enrolled, insurers would have to spread the costs among a smaller group of people, pushing premiums higher, said Edwin Park, a research professor at the Georgetown University McCourt School of Public Policy.
An earlier analysis from KFF, published this month, found that more than 22 million people could see a sharp premium increase starting Jan. 1.
'This is not a repeal [of the ACA], but it's certainly an attempt to move in that direction,' Park said. 'It'll be much more costly, so that means it'll be less affordable for you to purchase a plan or renew your coverage.'
Chris Meekins, a health policy research analyst at the investment firm Raymond James who served in the first Trump administration, said the chances that Congress will extend the subsidies in time for next year are slim, as Trump and other Republicans have signaled that they don't support them.
Higher out-of-pocket costs
ACA enrollment reached a record high last year, totaling more than 24 million people, according to the Centers for Medicare & Medicaid Services. Much of that growth was from the extended subsidies, the agency said. The average monthly premium was $113, compared with $162 in 2020.
According to KFF's latest analysis, most ACA insurers are proposing premium increases of 10% to 20% for 2026. More than a quarter, the group said, are proposing premium increases of 20% or more.
What people actually end up paying out of pocket for their monthly premiums could increase, on average, by more than 75%, Larry Levitt, the executive vice president for health policy at KFF, said on a call with reporters last week.
A family of three earning $110,000 a year and enrolled in a silver ACA plan — which usually comes with moderate monthly premiums — could see their monthly cost jump from $779 this year to $1,446 in 2026 when the enhanced subsidies expire, according to KFF. If insurers raise premiums by 15%, the monthly bill could climb even higher, to $1,662.
Some people may be able to keep their coverage by paying more in premiums each month or dropping down to so-called high-deductible plans, which have lower monthly premiums but require people to pay more out of pocket before coverage kicks in, Cynthia Cox, director of the program on the ACA, said on the same call.
Along with the other changes in the domestic policy bill, 'it amounts to what is effectively a partial repeal of the ACA, erasing a lot of its gain in health coverage,' Levitt said.
The subsidies on track to expire, however, aren't the only factor insurers are taking into account in their premium proposals, KFF's analysis found.
They're also concerned about the potential impact of tariffs on some drugs, medical equipment and supplies.
Earlier this month, Trump threatened to impose up to 200% tariffs 'very soon' on pharmaceuticals imported into the U.S. The majority of prescription drugs that people take in the U.S. are manufactured overseas.
Insurers also cited the anticipated growth in the cost of health care services, according to KFF. They also mentioned the cost of GLP-1 drugs, a class of medications that include the blockbuster drugs Ozempic and Wegovy. The drugs can cost more than $1,000 for a monthly supply.
On Thursday, a group of Democratic attorneys general filed a lawsuit to block a separate rule by the Trump administration that also makes changes to the ACA.
This article was originally published on NBCNews.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNBC
a minute ago
- CNBC
10-year Treasury yield climbs ahead of key services data
The 10-year Treasury yield inched higher as investors assessed developments related to U.S. President Donald Trump's tariff rates and looked toward data on July's services sector activity, slated for release later in the day. The benchmark 10-year note yield was over one basis point higher at 4.21% as of 4.15 a.m. ET, while the 30-year bond was less than one basis point higher at 4.801%. The 2-year Treasury note yield also climbed over 2 basis points to 3.702%. One basis point is equal to 0.01% and yields and prices move in opposite directions. The U.S. is expected to release the ISM non-manufacturing purchasing managers' index. Analysts polled by Reuters see the figure coming in at 51.5, up from 50.8 the previous month. Trump on Monday threatened to "substantially" increase tariffs on Indian goods, though he did not specify by how much. Last week, he floated a 25% levy and an additional "penalty" if India continues buying Russian oil. India pushed back against criticism from the U.S. and European Union over its purchases of Russian oil, saying it was being "targeted" unfairly after Trump warned of sharply higher tariffs. In a statement issued late Monday, India's Foreign Ministry said it only began buying oil from Russia after "traditional supplies" were redirected to Europe in the wake of the 2022 Russia-Ukraine war. "It is revealing that the very nations criticizing India are themselves indulging in trade with Russia. Unlike our case, such trade is not even a vital national compulsion [for them]," the ministry added, taking aim at the EU and U.S.


UPI
4 minutes ago
- UPI
Trump threatens India with tariffs over buying Russian oil
India Prime Minister Narendra Modi shakes hands with U.S. President Donald Trump in the Oval Office at the White House in Washington, on Thursday, February 13, 2025. On Monday, Trump threatened India with tariffs over its buying of Russia oil. File Photo by Francis Chung/UPI | License Photo Aug. 5 (UPI) -- U.S. President Donald Trump has threatened India with increased tariffs over its purchase of Russian oil amid Moscow's war in Ukraine. The American president issued his threat Monday in a statement published on his Truth Social media platform, accusing Delhi of not only buying "massive amounts" of Russian oil, but selling much of it on the open market for "big profits." "They don't care how many people in Ukraine are being killed by the Russian War Machine. Because of this, I will be substantially raising the tariff paid by India to the USA," Trump said. Trump has long seen tariffs as a tool to right trade deficits and as a bargaining tool. He has also started to use it as a punitive measure to retaliate against countries for taking actions he disagrees with. Last week, Trump imposed a 25% tariff on India as he imposed tariffs against dozens of nations. On Friday, the American president was asked about the situation, and said that he's heard India was to discontinue buying Russian crude. "That's what I heard. I don't know if that's right or not, but that's a good step," he said to a question about the percentage of tariffs he was considering imposing on the ally. "We'll see what happens. Over the weekend, India refuted the claims, stating it was not altering its policies. In response to Trump's threat on Monday, India accused the United States, and the European Union, of hypocrisy, saying they began importing from Russia "because traditional supplies were diverted to Europe after the outbreak of the conflict." "India's imports are meant to ensure predictable and affordable energy costs to the Indian consumer. They are a necessity compelled by global market situation," India's foreign ministry said in a statement. "However, it is revealing that the very nations criticizing India are themselves indulging in trade with Russia. Unlike our case, such trade is not even a vital national compulsion." It said the targeting of India was both "unjustified and unreasonable." "Like any major economy, India will take all necessary measures to safeguard its national interests and economic security."


CNBC
4 minutes ago
- CNBC
Oil little changed after hitting one-week low, oversupply concerns linger
Oil prices were little changed on Tuesday after three days of declines on mounting oversupply concerns after OPEC+ agreed to another large output increase in September, though the potential for more Russian supply disruptions supported the market. Brent crude futures were unchanged at $68.76 a barrel by 0036 GMT while U.S. West Texas Intermediate crude was at $66.27 a barrel, down 2 cents, or 0.03%. Both contracts fell by more than 1% in the previous session to settle at their lowest in a week. The Organization of the Petroleum Exporting Countries and its allies, together known as OPEC+, pumps about half of the world's oil and had been curtailing production for several years to support the market, but the group introduced a series of accelerated output hikes this year to regain market share. In its latest decision, OPEC+ agreed on Sunday to raise oil production by 547,000 barrels per day for September. It marks a full and early reversal of the group's largest tranche of output cuts, amounting to about 2.5 million bpd, or about 2.4% of global demand, though analysts caution the actual amount returning to the market will be less. At the same time, U.S. demands for India to stop buying Russian oil as Washington seeks ways to push Moscow for a peace deal with Ukraine is increasing concerns of a disruption to supply flows. U.S. President Donald Trump is threatening to impose 100% secondary tariffs on Russian crude buyers. This follows a 25% tariff on Indian imports announced in July. India is the biggest buyer of seaborne crude from Russia, importing about 1.75 million bpd of Russian oil from January to June this year, up 1% from a year ago, according to data provided to Reuters by trade sources. "India has become a major buyer of the Kremlin's oil since the 2022 invasion of Ukraine. Any disruption to those purchases would force Russia to find alternative buyers from an increasingly small group of allies," ANZ senior commodity strategist Daniel Hynes wrote in a note. Traders are also awaiting any developments on the latest U.S. tariffs on its trading partners, which analysts fear could slow down economic growth and dampen fuel demand growth.